NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.38 -1.56%

Quarterly report 2023-Q3
added 11-09-2023

report update icon

NeuBase Therapeutics Total Liabilities 2011-2024 | NBSE

Annual Total Liabilities NeuBase Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
9.5 M 10.1 M 3.15 M 2.5 M 725 K 5.08 M 4.48 M 3.88 M 5.27 M 480 K 1.09 M 6.19 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
10.1 M 480 K 4.37 M

Quarterly Total Liabilities NeuBase Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
9.48 M 11.1 M 7.01 M 7.36 M 9.5 M 9.68 M 10.6 M 9.91 M 10.1 M 9.04 M 10.1 M 2.24 M 3.15 M 3.15 M 3.15 M 2.85 M 2.5 M 2.5 M 2.5 M 530 K 291 K 725 K 597 K 3.75 M 5.08 M 5.08 M 5.08 M 3.89 M 4.48 M 4.48 M 4.48 M 5.28 M 3.88 M 3.88 M 3.88 M 6.78 M 5.27 M 5.27 M 5.27 M 250 K 480 K 480 K 480 K 2.38 M 1.09 M 1.09 M 1.09 M 5.53 M 6.19 M 6.19 M 6.19 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
11.1 M 250 K 4.62 M